ECE2016 Eposter Presentations Growth hormone IGF axis - basic (12 abstracts)
1Tashkent Pediatric Medical Institute, Tashkent, Uzbekistan; 2Republican Specialized Scientific-Practical Medical Center of Endocrinology under the Ministry of Health of the Republic of Uzbekistan, Tashkent, Uzbekistan.
Aim: To study the frequency of growth hormone deficiency (GHD) in patients with nonfunctional pituitary tumors (NFPA).
Materials and methods: Over a period of 1.0 year, we studied in our department retrospective data of 33 patients with pituitary tumors in terms of CT/MRI imaging and detailed hormonal functional assessment STH, IGF-1, LH, FSH, ACTH, prolactin, TSH, cortisol, thyroxine. From the patients are 11 men and 12 women, mean age of patients 38.5 years.
Results: Microadenomas (<10 mm) were found in 11 patients, mesoadenomas (1120 mm) in 11, macroadenomas (2030 mm) in 11 patients.
Panhypopituitarism (PH) was noted in six persons (18.3%), PH with diabetes insipidus in 5 (15.2%), isolated GHD in 7 (21.2%), GHD and LH deficiency in 2 (6.0%), GHD and LH, FSH deficiency in 11 patients (33.3%), GHD and LH, FSH, TSH deficiency in 2 (6.0%) Hypopituitarsin, that is, reduction in the levels of pituitary tropic hormones, such as, STH, LH and FSH was found in 75% (25 patients) large pituitary tumors with supra-, para- and infrasellar growth being registered in the patients.
Conclusions: The distribution of GHD in patients with NFPA has a lot of various disorders with combined deficiency of pituitary hormones levels.